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Abstract: RNA interference (RNAi) is a post-transcriptional gene-silencing process that 
occurs in many eukaryotic organisms upon intracellular exposure to double-stranded RNA. 
Argonaute 2 (Ago2) protein is the catalytic engine of mammalian RNAi. It contains a PIWI 
domain that is structurally related to RNases H and possibly shares with them a two-metal-
ion catalysis mechanism. Here we describe the expression in E. coli of mouse Ago2 and 
testing of its enzymatic activity in a RISC assay, i.e., for the ability to cleave a target RNA 
in a single position specified by a complementary small interfering RNA (siRNA). The 
results show that the enzyme can load the siRNA and cleave the complementary RNA in 
absence of other cellular factors, as described for human Ago2. It was also found that 
mutation of Arg669, a residue previously proposed to be involved in substrate and/or B 
metal ion binding, doesn’t affect the enzymatic activity, suggesting that this residue 
doesn’t belong to the active site. 
Keywords: RNA interference; microRNA; small interfering RNA; RNA-induced silencing 
complex 
__________________________________________________________________________________ 
1. Introduction 
RNA interference (RNAi) is a post-transcriptional gene-silencing process that occurs in many 
eukaryotic organisms upon intracellular exposure to double-stranded RNA (dsRNA) [1]. A 
ribonuclease (RNase) III family enzyme, Dicer, initiates silencing by processing dsRNA into ~20 bp 
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duplexes with two-nucleotide 3’ overhangs at both ends, called small interfering RNAs (siRNAs)  
[2–5]. The two strands of the siRNAs are then separated, and the one with the least stable 5’-end (the 
guide strand) is preferentially incorporated into the RNA-induced silencing complex (RISC), a 
ribonucleoprotein that uses its RNA component as a guide to endonucleolytically cleave 
complementary mRNAs [6−8]. RISC also mediates the function of endogenous, non-coding regulatory 
RNAs called microRNAs (miRNAs) [9,10]. 
The RISC component endowed with ribonucleolytic activity is Argonaute 2 (Ago2), a protein 
characterized by PAZ and PIWI domains, with the latter comprising the catalytic center [11,12]. The 
crystal structure of full-length Argonaute from Pyrococcus furiosus (PfAgo) has shown that the PIWI 
domain has an RNase H fold with two catalytic aspartates in positions identical to those found in other 
RNase H family enzymes [13]. These residues and an adjacent histidine bind a divalent metal ion 
(Mg
2+ or Mn
2+) and play a crucial role in catalysis [14]. Additional insights into the catalytic 
mechanism of Argonaute proteins have been provided by the determination of the crystal structure of 
Bacillus halodurans RNase H (Bh-RNase H) in complex with an RNA:DNA hybrid [15]. This study 
revealed that substrate binding is mediated by two Mg
2+ ions. The first one (metal ion A) is equivalent 
to the metal ion observed in the crystal structure of PfAgo and is required for substrate-assisted 
nucleophile formation. The second magnesium ion (metal ion B), which is expected to stabilize the 
pentacovalent reaction intermediate, was found to be coordinated by the same two aspartates that bind 
metal ion A, a glutamate, and two oxygen atoms of the scissile phosphate. It was then proposed that 
metal ion B, not observed in the crystal structure of PfAgo, may bind to the active site of Argonautes 
upon interaction with the substrate [15]. 
Heterologous cell systems for protein expression and site-directed mutagenesis are very useful tools 
to inquire the mechanism of enzymatic reaction. Despite the great interest for Argonaute proteins and 
RNA interference, only two mammalian Argonautes, human Ago1 and Ago2 have been expressed and 
subjected to mutational studies [12,14,16]. Here we report the development of an expression system in 
Escherichia coli for mouse Argonaute 2 (mAgo2) that is suitable for functional and mutational studies. 
2. Results and Discussion 
2.1. Expression in E. Coli and Purification of Mouse Argonaute 2 
In order to express in E. coli mAgo2, its coding sequence [16] was cloned into the expression 
vector pMAL-c2e in frame with the 3’ end of the DNA encoding the maltose binding protein (MBP) to 
obtain pMAL-mAgo2 (Figure 1). In this vector, transcription is directed by the Ptac promoter and the 
encoded protein comprises the polypeptide chain of mAgo2 (859 amino acid residues) fused to the  
C-terminus of the MBP (388 amino acid residues). The choice of this vector followed several trials 
with other expression plasmids that failed to yield any soluble expression products. 
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Figure 1. Construction of the expression vector pMAL-mAgo2. The cDNA coding for 
mouse Ago2 was cloned in frame with the 3’ end of the DNA encoding the maltose 
binding protein (MBP), under the transcriptional control of Ptac promoter. For description 
see the text. 
 
Plasmid pMAL-mAgo2 was then used to transform cells of the Rosetta™ E. coli strain. After 
induction with IPTG, the expression of MBP-mAgo2 fusion protein was assessed by SDS–PAGE 
analysis of the bacterial lysates (Figure 2A). The comparison of the protein patterns derived from 
induced and uninduced cells showed a band with the molecular size (~140 kDa) of the expected 
expression product (Figure 2A). Based on a densitometric analysis of the gel, the lysate derived from 
0.5 L of bacterial culture contained ~3 mg of the fusion protein. The bacterial lysate from induced cells 
was then centrifuged and both the pellet and the supernatant were analyzed by SDS-PAGE to assess 
the solubility of the expression product. As shown in Figure 2A, a substantial amount of MBP-mAgo2 
was found in the soluble phase of the bacterial lysate. 
The bacterial extract was then subjected to an affinity chromatography with an amylose resin, using 
maltose for elution of bound proteins. SDS-PAGE analysis of the eluate revealed a substantial 
enrichment of the expression product that accounted for about 40% of the total proteins (Figure 2B). 
Its identity was then verified by the analysis the N-terminal amino acid sequence after blotting on a 
polyvinylidene fluoride membrane. Next, several attempts were made to improve the purity of the 
protein sample by (1) varying the conditions for the affinity chromatography and (2) introducing a  Int. J. Mol. Sci. 2010, 11                 
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gel-filtration step, but they were unsuccessful. It was also noticed that MBP-mAgo2 precipitated upon 
storage at -20 °C or -80 °C but it was stable at 4 °C for at least two days (Figure 2B), enough to 
perform the enzymatic assays. 
 
Figure 2. Expression and purification of MBP-mAgo2. Panel A: SDS-PAGE of lysates 
from uninduced (lane 2) and induced (lane 3) E. coli cells transformed with the expression 
vector pMAL-mAgo2; lanes 4 and 5 contain the insoluble and soluble phases of the 
bacterial lysate from induced cells, respectively; circles mark the expression product. Panel 
B: Protein sample eluted from the affinity chromatography on the amylose resin (lane 1); 
lanes 2 and 3 contain the soluble and insoluble phases of the eluate obtained by its 
centrifugation after two days of storage at 4 °C. 
 
2.2. Functional Characterization of Mouse Argonaute 2 
Recombinant mAgo2 was then tested in a RISC assay, i.e., for the ability to cleave a target RNA in 
a single position specified by a complementary siRNA [9]. For this purpose, mAgo2 was preincubated 
with a 5’-phosphorylated 21-mer guide oligoribonucleotide to form a minimal RISC. This complex 
was then mixed with a synthetic 50-mer RNA substrate that had been labeled with 
32P at its 5’-end. 
The rationale for using this assay is that the binding of RISC to the substrate will produce a cleavage at 
a single position opposite to the phosphate between nucleotides 10 and 11 of the guide RNA. This will 
yield an unlabeled 28-mer product, and a labeled 22-mer corresponding to the 5’-fragment of the 
substrate, that can be revealed by denaturing PAGE followed by autoradiography. Obviously, this 
assay can be performed only if the enzyme sample is free of contaminating RNases that would 
otherwise degrade the substrate aspecifically. The electrophoretic analysis of the reaction products 
obtained with mAgo2 (Figure 3) revealed a band with the same mobility of a 22-mer marker, as 
expected for Argonaute 2 with a canonical enzymatic activity. No reaction product was detected when Int. J. Mol. Sci. 2010, 11                 
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the assay was performed in the absence of mAgo2 or guide RNA. Finally, a reaction mixture 
containing mAgo2 and a guide RNA with unrelated sequence did not yield the 22-mer product   
(Figure 3). It should be noted that in these controls some aspecific degradation of the substrate also 
occurred, but none of the products comigrated with the Ago2-generated 22-mer product. Overall, these 
data indicate that mAgo2 expressed in E. coli can be loaded with a guide siRNA in absence of other 
cellular factor(s) and is able to cleave the target RNA at a single site that is dictated by the nucleotide 
sequence of the RNA cofactor, as described for human Ago2. 
Figure 3. RISC assay for MBP-mAgo2. The enzyme was loaded with the guide siRNA and 
then incubated with a synthetic 50-mer RNA substrate that had been labeled with 
32P at its 
5’-end. Reaction products were revealed by denaturing PAGE followed by 
autoradiography. They included an unlabeled 28-mer product (not visible in the 
autoradiography) and a labeled 22-mer. Lane 1, molecular marker; lanes 2-7, reaction 
mixtures containing the labeled substrate, mAgo2 and/or the guide siRNA, as specified in 
the top of the figure; ur indicates a guide RNA with unrelated sequence, i.e., not 
complementary to the substrate. Reaction mixtures contained 140 ng (lanes 4-6) or 280 ng 
(lane 7) of mAgo2. 
 
2.3. Mutational Analysis of mAgo2 
It has been proposed that Argonaute 2 shares with RNase H a two-metal-ion catalysis mechanism 
[15]. It has also been proposed that Arg627 of P. furiosus Argonaute, equivalent to Arg669 of the 
murine protein, may be an active-site residue, possibly involved in substrate and/or B metal ion 
binding [15]. To test this hypothesis, we prepared a mutant mAgo2 with Arg669 replaced by an 
alanine (R669A mAgo2) and assayed it for RISC activity. As shown in Figure 4, a band corresponding 
to the 22-mer reaction product was clearly detectable, indicating that the R669A mAgo2 is 
enzymatically active. This result demonstrates that Arg669 of mAgo2 is dispensable for catalysis, and 
suggests that, if this residue really binds the metal ion B, an adjacent residue can functionally replace Int. J. Mol. Sci. 2010, 11                 
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it. On the other hand, the results show that the bacterial expression system for mAgo2 is suitable for 
mutational studies. 
 
Figure 4. RISC assay for R669A mAgo2. Samples were treated as described in the legend 
of Figure 3. Lane 1, molecular marker; lanes 2-4, reaction mixtures containing the labeled 
substrate, the guide siRNA and the indicated amounts of R669A mAgo2. 
 
3. Experimental Section 
3.1. Materials and General Procedures 
The expression vector pMAL-c2e and the amylose resin were obtained from New England Biolabs. 
SDS–PAGE analyses were performed according to Laemmli [17] using 10% (w/v) polyacrylamide 
gels that were stained with Coomassie blue. Plasmid pBS-mAgo2 [16], containing mAgo2 cDNA, was 
kindly provided by Dr. K. Saigo from the University of Tokyo. Oligonucleotides were purchased  
from Invitrogen. 
3.2. DNA Cloning and Site-Directed Mutagenesis 
The coding sequence of mAgo2 cDNA, was transferred in the expression vector pMAL-c2e by two 
cloning steps. In the first step, the 5’-end of the cDNA was obtained by PCR amplification of pBS-
mAgo2 [16] with an upstream primer (5’-GGGGTACCGTACTCGGGAGCGGC-3’) and a 
downstream primer (5’-CCCAAGCTTCACTTGATGGATACCTTTAAGATG-3’) containing Kpn  I 
and Hind III restriction sites (underlined), respectively. The amplification product was digested with 
Kpn I and Hind III and cloned into the same sites of pMAL-c2e to obtain pMAL-NmAgo2 (Figure 1). 
In the second step, the remaining part of coding sequence was excised from pBS-mAgo2 by cleavage Int. J. Mol. Sci. 2010, 11                 
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with  Sma  I and Hind  III and cloned in the same sites pMAL-NmAgo2 (Figure 1). The resulting 
expression vector, containing the entire coding sequence, was designated pMAL-mAgo2. 
Site-directed mutagenesis was performed by replacement of a Stu I-Stu I wild-type segment of 
pMAL-mAgo2 (Figure 1) with a mutated DNA fragment obtained by PCR. The reaction was 
performed using an upstream primer (5’-CACCTGAAGAACACATACGCTG-3’) and a mutagenic 
downstream primer (5’-GCAGGCCTCTCTGATGGCCAGGAGCTCATGGTGGAGAACCTGCTGG 
AACTGGCCCTCGGAGACGCCATCGGCGTAG-3’;  Stu  I site is underlined and the mutated 
nucleotides are in marked in bold). The amplification product, containing the mutated site, was 
digested with Stu I and ligated into the vector to obtain pMAL-mAgo2 R669A. The structural 
identities of the wild-type and mutated expression vectors were verified by restriction analysis and  
DNA sequencing. 
3.3. Protein Expression and Purification 
The expression plasmid pMAL-mAgo2, containing the cDNA sequence coding for mAgo2, and the 
mutant plasmid pMAL-mAgo2 R669A were separately used to electroporate cells of the E. coli strain 
Rosetta™ (DE3) (Novagen). Transformed cells were then cultured at 37 °C in 0.5 l of LB broth 
containing 2 g/L glucose and 100 μg/mL ampicillin. When the absorbance of the culture at 600 nm 
reached a value of 0.5, cells were induced with 0.3 mM isopropyl β-D-thiogalactopyranoside (IPTG) at 
25 °C for 4 h. Bacteria were then harvested by centrifugation at 4,000g for 10 min and washed with  
250 mL of buffer A (50 mM Tris-Cl, 50 mM NaCl, 2 mM MgCl2, 10% glycerol, pH 7.4). Cells were 
resuspended in 100 mL of buffer A containing 4 mM DTT, disrupted by a French press operated at 
1,800 psi, and centrifuged at 10,000g for 15 min at 4 °C. The resulting cell extract was then divided in 
10 aliquots: one was processed for protein purification and the others were stored at -80 °C. The 
sample was mixed with 0.25 mL of amylose resin equilibrated with buffer A containing 4 mM DTT 
and incubated at room temperature on a rocking platform for 3 h. The resin was then washed twice 
with 3 mL of the same buffer and bound proteins were eluted with 0.3 mL of buffer A containing  
4 mM DTT and 10 mM maltose. The eluate was then analyzed by SDS-PAGE and the expression 
product was quantitated by densitometric analysis of the gel. The final protein sample was stored at  
4 °C and used for the enzymatic assays within 24-36 hours. 
3.4. Structural and Functional Analyses 
Protein sequence analyses were performed by automated Edman degradation of the polypeptide 
chain with an Applied Biosystems sequencer Procise™ model 491, equipped with a high-pressure 
liquid chromatography apparatus for identification of phenylthiohydantoin derivatives. The enzymatic 
activity of mAgo2 was tested by a gel-based assay, as described [14]. Briefly, a minimal RISC was 
assembled by incubating mAgo2 with a single-stranded 5’-phosphorylated siRNA   
(5’-UCGAAGUACUCAGCGUAAGdTdT-3') in 20 µL of 50 mM Tris-Cl pH 7.4, containing 50 mM 
NaCl, 2 mM MgCl2, and 4 mM DTT, at 37 °C for 30 min. The sample was then supplemented with  
1 μL of RNA substrate (5’-GAGGUGGACAUCACUUACGCUGAGUACUUCGAAAUGUCCGUUC 
GGUUGGC-3’), previously 
32P-labeled at its 5’-end with T4 polynucleotide kinase and gel-purified. Int. J. Mol. Sci. 2010, 11                 
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The resulting reaction mixture, containing ~100,000 c.p.m., was incubated at 42 °C for 1 h and 
analyzed on a 6% polyacrylamide gel containing 8 M urea, followed by autoradiography. 
4. Conclusions 
Despite the great interest in Argonaute proteins and RNA interference, only one bacterial 
expression system for a eukaryotic Argonaute has been described so far [14]. It allows the expression 
of human Ago2 fused to Glutathione S-transferase (GST). However, the expression product was found 
to be poorly soluble and required coexpression of Heat shock protein 90 (HSP90) from a vector that is 
not commercially available. The present study shows that mouse Ago2 can be expressed as a fusion 
protein with the maltose binding protein in a soluble and enzymatically active form, without requiring 
coexpression with chaperones. We are aware that the final protein product is not sufficiently pure for 
structural studies. Nevertheless, the level of enzyme enrichment achieved with the affinity 
chromatography is sufficiently high to perform the RISC assay without suffering from the interference 
of contaminating RNases. This expression system is hence suitable for functional studies on Argonaute 
2 and provides an additional tool to analyze the process of RNA interference. This may be particularly 
relevant for those studies that are performed on mouse models. 
The results also contribute to the understanding of the catalytic mechanism of Ago2 by providing 
additional evidence that the enzyme can load the siRNA and cleave the complementary RNA in 
absence of other cellular factors. Finally it was found that mutation of Arg669, a residue previously 
proposed to be involved in substrate and/or B metal ion binding [15], to alanine doesn’t affect the 
enzymatic activity, suggesting that this residue doesn’t belong to the active site. 
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